OR MPJE study materials
OR MPJE study resources

Death With Dignity Prescription: The 15-Day Oral Request Clock

OR MPJE · Put your knowledge to work in context.

All case studies

Death With Dignity Prescription: The 15-Day Oral Request Clock

A 68-year-old man with metastatic pancreatic cancer and a hospice prognosis of less than six months asks his Oregon attending physician for aid-in-dying medication. The physician writes a Schedule II prescription for secobarbital 100 mg capsules, quantity 90, with directions to take all at once. The written request is dated 10 days ago and is properly signed and witnessed. The first oral request was made 12 days ago, and the second oral request was made yesterday. A consulting physician's note confirms the patient is capable and has no depression. When the patient comes to the pharmacy, he is tearful and says, 'I don't see the point anymore.' His daughter calls and says, 'Don't fill it; he's depressed.' The pharmacist has no conscientious objection but is unsure whether the timelines have been met.

1. May the pharmacist dispense the secobarbital today? Identify each Oregon Death With Dignity Act requirement and apply the facts.

Read the worked answer

No. Oregon's Death With Dignity Act requires a capable adult with a terminal illness and a prognosis of six months or less, two oral requests separated by at least 15 days, a written request signed and witnessed, a waiting period of at least 48 hours after the written request before the attending physician writes the prescription, a consulting physician confirmation, and a referral for counseling if either physician suspects depression or impaired judgment. The pharmacist must also be informed of the purpose of the prescription. Here the written request was 10 days ago, so the 48-hour waiting period after the written request appears satisfied, and the consulting note is present. But the two oral requests were only 12 days apart, not 15. The statutory clock has not run. Dispensing today would violate Oregon law even though the prescription is otherwise complete. The pharmacist should explain the timeline to the patient or attending physician and document the calculation. The prescription may remain on file, but it should not be filled until the 15-day interval has passed and the other requirements remain satisfied.

2. How should the pharmacist handle the patient's tearfulness and the daughter's objection?

Read the worked answer

The pharmacist should treat the patient's statement as a possible sign of depression or impaired judgment, not as routine sadness. Oregon law requires the attending or consulting physician to refer the patient for counseling if depression or impaired judgment is suspected. The pharmacist should contact the attending physician, describe the observation, and ask for a mental health evaluation before any dispensing. The daughter's objection does not by itself override the patient's decision; a capable patient may choose aid in dying, and family members do not have a legal veto. However, the pharmacist should not discuss the patient's care with the daughter without the patient's authorization. If the patient consents, the pharmacist may listen to the daughter and explain that the care team will assess the patient. The pharmacist should document the observation, the physician contact, the daughter's call, and the decision to pause. If the patient is acutely suicidal or in crisis, the pharmacist should follow emergency protocols.

3. What federal and state controlled-substance issues apply to dispensing secobarbital under the Act, and what if the pharmacist later develops a conscientious objection?

Read the worked answer

Secobarbital is a Schedule II controlled substance, so the prescription must meet federal controlled-substance requirements: it must be issued by a DEA-registered practitioner for a legitimate medical purpose, it may not be refilled, and the pharmacist must verify the prescription and the prescriber's registration. Oregon's Death With Dignity Act provides a state-law pathway for the prescription, but it does not eliminate the federal registration and recordkeeping requirements. The pharmacist should verify the prescriber, confirm the patient's identity, and follow Oregon PDMP reporting and record retention rules for the Schedule II dispensing. If the pharmacist later develops a conscientious objection, Oregon law allows a health care provider to decline to participate, but the pharmacist must not abandon the patient. The pharmacist should transfer the prescription and relevant records to a willing pharmacist or pharmacy and document the transfer. The pharmacist should not confiscate the prescription or disclose the patient's information improperly.